Found: 26
Select item for more details and to access through your institution.
Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 203, doi. 10.1007/s10549-019-05157-4
- By:
- Publication type:
- Article
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 247, doi. 10.1007/s10549-019-05156-5
- By:
- Publication type:
- Article
Change in study randomization allocation needs to be included in statistical analysis: comment on 'Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study'
- Published in:
- 2019
- By:
- Publication type:
- Letter
Tamoxifen and pregnancy: an absolute contraindication?
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 17, doi. 10.1007/s10549-019-05154-7
- By:
- Publication type:
- Article
An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 59, doi. 10.1007/s10549-019-05147-6
- By:
- Publication type:
- Article
Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 91, doi. 10.1007/s10549-019-05153-8
- By:
- Publication type:
- Article
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 149, doi. 10.1007/s10549-018-05110-x
- By:
- Publication type:
- Article
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 51, doi. 10.1007/s10549-019-05148-5
- By:
- Publication type:
- Article
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 217, doi. 10.1007/s10549-019-05152-9
- By:
- Publication type:
- Article
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 39, doi. 10.1007/s10549-019-05146-7
- By:
- Publication type:
- Article
Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 117, doi. 10.1007/s10549-019-05128-9
- By:
- Publication type:
- Article
HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment.
- Published in:
- 2019
- By:
- Publication type:
- Letter
The effects of psychosexual counseling on sexual quality of life and function in Iranian breast cancer survivors: a randomized controlled trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 171, doi. 10.1007/s10549-019-05140-z
- By:
- Publication type:
- Article
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 239, doi. 10.1007/s10549-019-05139-6
- By:
- Publication type:
- Article
Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 191, doi. 10.1007/s10549-019-05136-9
- By:
- Publication type:
- Article
Factors influencing the use of extended adjuvant endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 181, doi. 10.1007/s10549-019-05145-8
- By:
- Publication type:
- Article
Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 165, doi. 10.1007/s10549-019-05143-w
- By:
- Publication type:
- Article
ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 77, doi. 10.1007/s10549-018-05126-3
- By:
- Publication type:
- Article
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 1, doi. 10.1007/s10549-018-05117-4
- By:
- Publication type:
- Article
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 229, doi. 10.1007/s10549-018-05116-5
- By:
- Publication type:
- Article
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 129, doi. 10.1007/s10549-018-05097-5
- By:
- Publication type:
- Article
Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 141, doi. 10.1007/s10549-018-05123-6
- By:
- Publication type:
- Article
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 27, doi. 10.1007/s10549-018-05111-w
- By:
- Publication type:
- Article
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 5, doi. 10.1007/s10549-018-05102-x
- By:
- Publication type:
- Article
Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 105, doi. 10.1007/s10549-018-05113-8
- By:
- Publication type:
- Article
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice